Cigna explores shedding Medicare Advantage business 

DealsGovernmentHealth 06 November 2023, 6:28 pm 1 minute Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and older, a move that would mark a reversal of its expansion in the sector.   Market Impact…

Lilly to build $2.5 billion Germany plant as obesity drug demand soars

DealsHealth 17 November 2023, 11:31 am 1 minute Reuters exclusively reported that Eli Lilly (LLY.N) will build its first plant in Germany in the western town of Alzey for 2.3 billion euros ($2.5 billion), the U.S. drugmaker said on Friday, as the sector scrambles to meet soaring demand for new diabetes and obesity therapies.  Market…

US FDA finds control lapses at Moderna manufacturing plant 

Health 15 December 2023, 9:42 am 1 minute Reuters exclusively reported that U.S. drug regulators in September found quality control lapses at Moderna’s (MRNA.O) main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine.  Market Impact Moderna in September said it was in talks with its partners that fill vials and…

ECB sounds out lenders on exposure to Spanish drugmaker Grifols 

Business & FinanceHealth 17 January 2024, 5:59 pm 1 minute Reuters exclusively reported that the European Central Bank was asking banks to detail their exposure to Spanish drugmaker Grifols and a network of companies linked to the founding family, days after the Barcelona-based business was accused of manipulating its financial accounts by a short-seller. The…

Eli Lilly could launch obesity drug in India next year

Health 28 February 2024, 12:55 pm 1 minute Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review.  Market Impact The market opportunity is huge in the world’s most…

Gratitude for veterans, plus Trump’s stamina impresses doctors

Fox News’ Health newsletter brings you stories on the latest developments in health care, wellness, diseases, mental health and more. TOP 3: – For Veterans Day, USAA honors those who have served with “national moment of gratitude” – Trump’s stamina at age 78 impresses the experts – Ivanka Trump shares 17 life lessons she’s learned…

Pharmacies vote to reduce services in first protest action

MARK MARLOW/EPA-EFE/REX/Shutterstock This is the first time pharmacists have voted to take action in their history Pharmacy owners in England, Wales and Northern Ireland have voted in favour of cutting opening hours and stopping home deliveries for the first time, in a protest over government funding. The National Pharmacy Association (NPA), which ran the ballot,…

Charity calls for prostate-cancer testing of high-risk men

Getty Images Screening men born with a high risk of developing prostate cancer, once they reach the age of 45, makes financial sense, a cancer charity says. But Prostate Cancer Research also acknowledges more accurate tests would be needed to justify screening all men. There is no prostate-cancer screening programme in the UK, unlike those…

Major Bayer shareholder Harris backs CEO’s focus on internal restructuring 

Business & FinanceHealth 07 March 2024, 1:56 pm 1 minute Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO.  Market Impact The news caused Bayer’s shares to significantly narrow…

Novo Nordisk says experimental drug amycretin show 13% weight loss in trial 

Business & FinanceHealth 07 March 2024, 2:04 pm 1 minute Reuters was first to report on the early trial data for Novo Nordisk’s highly anticipated experimental drug amycretin which showed that participants had a weight loss of 13.1% after 12 weeks, prompting the company’s shares to rise to record highs and placing it above Tesla…

End of content

End of content